XML 205 R180.htm IDEA: XBRL DOCUMENT v3.10.0.1
IFRS 7 Disclosures - Additional Information (Detail)
$ in Millions
12 Months Ended
Dec. 31, 2018
USD ($)
Dec. 31, 2017
CAD ($)
Dec. 31, 2018
CAD ($)
Dec. 31, 2018
USD ($)
Financial Instruments - Disclosures under IFRS 7 [line items]        
Total unencumbered assets   $ 396,800 $ 427,900  
Dynamically hedged variable annuity guarantee best estimate liabilities, rebalancing percentage intervals 5.00%      
Sensitivity of net income attributed to shareholders 0.50%      
Variable annuity guarantee liabilities, rebalanced basis point intervals 0.20%      
50 basis point decrease in interest [member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Sensitivity of our net income attributed to shareholders due to change in interest rate $ 100,000,000      
50 basis point increase in interest [member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Sensitivity of our net income attributed to shareholders due to change in interest rate $ 100,000,000      
Unsecured revolving credit facility [Member] | Canadian chartered banks [Member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Estimated maximum borrowing capacity     $ 500  
Unsecured revolving credit facility [Member] | U.S.banks [Member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Estimated maximum borrowing capacity       $ 500,000,000
Amounts outstanding       0
FHLBI facility [Member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Estimated maximum borrowing capacity       3,800,000,000
Amounts outstanding       $ 0
10% [member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Percentage of expected changes in market values of publicly traded equities 10.00% 10.00%    
20% [member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Percentage of expected changes in market values of publicly traded equities 20.00% 20.00%    
30% [member]        
Financial Instruments - Disclosures under IFRS 7 [line items]        
Percentage of expected changes in market values of publicly traded equities 30.00% 30.00%